June 26, 2019 Price forecast | 2 weeks: 3.69% | 1 month: 3.31% | 3 months: 2.57%


ODT stock forecast

Our latest prediction for Odonate Therapeutics, Inc.'s stock price was made on the June 26, 2019 when the stock price was at 31.76$.

In the short term (2weeks), ODT's stock price should outperform the market by 3.69%. During that period the price should oscillate between -9.16% and +13.01%.

In the medium term (3months), ODT's stock price should outperform the market by 2.57%. During that period the price should oscillate between -19.93% and +30.16%.


About Odonate Therapeutics, Inc.

Odonate Therapeutics, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in San Diego, CA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -4.11$ per share.

The book value per share is 6.41$

Odonate Therapeutics, Inc. website


Three months stock forecastJune 26, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -103M - -101M -4.11 - - 25M 6.41 -82M -2M -84M